The EC grants the European marketing authorization to StrimvelisTM
GlaxoSmithKline (GSK), Fondazione Telethon (Telethon) and Ospedale San Raffaele (OSR) announced that the European Commission...
Positive CHMP opinion in EU for saxa/dapa (saxagliptin and dapagliflozin) for adults with type-2...
AstraZeneca announced that the Committee for Medicinal Products for Human Use (CHMP) of the European...
European CHMP Adopts Positive Opinion for Gilead’s Epclusa for the Treatment of All Genotypes...
Gilead Sciences Inc announced that the Committee for Medicinal Products for Human Use (CHMP), the...
U.S. FDA Approves CSL Behring’s AFSTYL for adults and children with haemophilia A
CSL announced that the US Food and Drug Administration (FDA) has approved AFSTYLA® , CSL...
EISAI To Launch In-House Developed Antiepileptic Drug Fycompa (Perampanel Hydrate) As Adjunctive Therapy For...
Eisai Co Ltd announced that it will launch its in-house-discovered antiepileptic drug (AED) Fycompa® Tablets...
FDA Recommends Approval Of Sanofi Treatment For Adults With Type 2 Diabetes
Sanofi announced that the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) of the U.S. FDA...
GSK, Fondazione Telethon and Ospedale San Raffaele announce publication of pivotal safety and efficacy...
GSK, Fondazione Telethon and Ospedale San Raffaeletoday announced the publication in BLOOD of the long-term...
Daiichi Sankyo Launches Antiplatelet Agent Efient® Tablets 20mg
Daiichi Sankyo Company, Limited announced that it has launched the antiplatelet agent Efient® Tablets 20mg...
Novartis highlights its strong foundation for long-term, sustainable growth at the third Meet Novartis...
Outlines actions underway to accelerate launch of Entresto®, including further expansion of US primary...
Bayer Comments on Monsanto’s Statement Regarding Proposed Transaction
Bayer announced that it looks forward to engaging in constructive discussions with Monsanto regarding the...
